Highland Capital Management (Tennessee)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Highland Capital Management (Tennessee)'s BIIB Position: Q4 2020 in Review
Highland Capital Management (Tennessee) sold out of Biogen (BIIB) in Q4 2020, closing a stake of 12,236 shares — an estimated $3.47M sold.
Highland Capital Management (Tennessee) first reported a position in BIIB in Q2 2015 and held it in 20 quarters. The position peaked at $3.89M in Q1 2020. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.
- Highland Capital Management (Tennessee) reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
- Highland Capital Management (Tennessee) sold 12,236 Biogen shares in Q4 2020, an estimated $3.47M.
- Highland Capital Management (Tennessee) first reported a position in Biogen in Q2 2015 and held it in 20 quarters.
- Highland Capital Management (Tennessee)'s Biogen position peaked at $3.89M in Q1 2020.
- 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.
Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2020, filed 21 Jan 2021.